Protagonist Therapeutics CEO gifts 300 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Protagonist Therapeutics, Inc. (PTGX) President and CEO Dinesh V. Ph D. Patel reported a bona fide gift of 300 common shares to a relative on November 19, 2026. After the gift, he reported direct holdings of 522,668 shares.
Insider Trade Summary
300 shares gifted
Gift
1 txn
Insider
PATEL DINESH V PH D
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock F1 | 300 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 522,668 shares (Direct)
Footnotes (1)
- F1. This transaction involves a bona fide gift of securities from the Reporting Person to a relative.
Key Figures
Shares gifted: 300 shares
Direct holdings after gift: 522,668 shares
2 metrics
Shares gifted
300 shares
Gift to a relative on November 19, 2026
Direct holdings after gift
522,668 shares
Reported after the gift
Key Terms
bona fide gift
1 terms
bona fide gift regulatory
"bona fide gift of securities from the Reporting Person to a relative"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.